HAWTHORNE, Calif. - OSI Systems , Inc. (NASDAQ:OSIS) has been awarded a $15 million contract to supply electronic sub-assemblies to a healthcare original equipment manufacturer (OEM). The company, known for its advanced medical technology solutions, has chosen OSI Systems' Optoelectronics and Manufacturing division for this significant order.
Chairman and Chief Executive Officer of OSI Systems, Deepak Chopra, expressed satisfaction with the new contract, emphasizing the company's dedication to quality and its capability to fulfill the demands of sophisticated medical technology providers.
The announcement does not delve into specifics about the type of electronic sub-assemblies or the exact applications they will be used for. However, it underscores OSI Systems' role in supporting innovative healthcare technologies through its manufacturing capabilities.
This business development is indicative of OSI Systems' continued partnership with key players in the healthcare industry, although the press release does not disclose the name of the healthcare OEM involved.
OSI Systems has advised caution regarding forward-looking statements, noting that they reflect current expectations and projections about future events. These statements are not guarantees of future performance and are subject to uncertainties and risks. The company acknowledges that actual results may differ from those projected due to various factors beyond their control.
Investors and interested parties are reminded that the information in this article is based on a press release statement and should consider the inherent risks and uncertainties outlined by OSI Systems in their disclosures.
The financial details of the agreement, such as payment terms or expected delivery dates for the electronic sub-assemblies, were not provided in the press release. OSI Systems has not commented on whether this order will have a material impact on its financial performance or guidance for the current fiscal year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.